|
CD46 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.222300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.838300E-02 |
| Normal-vs-Stage2 |
7.002600E-01 |
| Normal-vs-Stage3 |
2.660200E-01 |
| Normal-vs-Stage4 |
2.884300E-02 |
| Stage1-vs-Stage2 |
1.002010E-01 |
| Stage1-vs-Stage3 |
7.218600E-01 |
| Stage1-vs-Stage4 |
1.668360E-01 |
| Stage2-vs-Stage3 |
1.899370E-01 |
| Stage2-vs-Stage4 |
1.835680E-02 |
| Stage3-vs-Stage4 |
1.352600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.385850E-01 |
| Normal-vs-AfricanAmerican |
2.769800E-02 |
| Normal-vs-Asian |
2.753000E-01 |
| Caucasian-vs-AfricanAmerican |
8.697900E-02 |
| Caucasian-vs-Asian |
7.878800E-01 |
| AfricanAmerican-vs-Asian |
1.491950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.303600E-01 |
| Normal-vs-Female |
7.447800E-02 |
| Male-vs-Female |
6.731000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.907700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.604800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.164200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.583180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.486600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.599800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.784800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.771000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.990800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.547400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.294600E-01 |
| Classical-VS-Follicular |
3.557100E-04 |
| Classical-VS-Other |
9.791600E-02 |
| Classical-VS-Normal |
6.683800E-03 |
| Tall-VS-Follicular |
6.493800E-02 |
| Tall-VS-Other |
3.678000E-01 |
| Tall-VS-Normal |
1.729600E-01 |
| Follicular-VS-Other |
8.184200E-01 |
| Follicular-VS-Normal |
4.712600E-01 |
| Other-VS-Normal |
9.082600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.780800E-01 |
| Normal-vs-N1 |
1.788410E-01 |
| N0-vs-N1 |
1.389990E-01 |
|
|
